Aberrently glycosylated ACE2 in the lung, nasal airways, tongue, and oropharynx in uncontrolled hyperglycemia could increase SARS‐CoV‐2 viral binding sites, thus leading to a higher propensity to COVID‐19 infection and a higher disease severity. This evidence concerns the gene ACE2 and Hyperglycemia.